Tue Oct 01 09:14:41 UTC 2024: ## Hedge Fund Activity and Insider Trading Shake Up AdaptHealth Corp. (AHCO)

**New York, NY (October 1, 2024)** – AdaptHealth Corp. (NASDAQ:AHCO) is experiencing significant changes in its shareholder landscape, with several hedge funds adjusting their positions and insiders making notable stock sales.

XTX Topco Ltd, a prominent hedge fund, notably decreased its stake in AdaptHealth by 45.9% during the second quarter. This move, detailed in the fund’s recent 13F filing, signifies a reduced confidence in the company’s future prospects.

However, other investors remain optimistic. Vanguard Group Inc. increased its stake by 8.9%, while Reinhart Partners LLC and Dimensional Fund Advisors LP also saw significant gains in their holdings. First Eagle Investment Management LLC and Bank of New York Mellon Corp rounded out the notable increases, indicating sustained institutional interest in the company.

Meanwhile, insider trading activity also raised eyebrows. AdaptHealth’s COO, Shaw Rietkerk, sold 25,000 shares on September 20th, further contributing to the mixed signals surrounding the company’s future. Similarly, Director David Solomon Williams III sold 4,000 shares in August.

Despite the mixed signals, AdaptHealth’s recent quarterly earnings results, released on August 6th, saw the company fall short of analyst estimates. The firm reported $0.13 EPS, missing the consensus estimate of $0.19. Although revenue reached $805.98 million, exceeding the consensus estimate of $802.62 million, the overall financial picture remains uncertain.

Analysts remain divided on AdaptHealth’s future trajectory. While Royal Bank of Canada issued an “outperform” rating with a $13.00 price target, other analysts remain cautious. MarketBeat.com currently shows a consensus rating of “Hold” and a consensus price target of $10.70.

AdaptHealth, a leading provider of home medical equipment and services in the United States, continues to navigate a complex market landscape. Investors will closely monitor the company’s performance and the evolving investment sentiment surrounding its stock in the coming months.

Read More